Q1 2026 Weight Loss Trends: What the Data Shows
Hi community! I've been analyzing peptide research trends and wanted to share some interesting data patterns I'm seeing in Q1 2026. **Top Researched Peptides for Fat Loss:** 1. Tirzepatide (dual GIP/GLP-1) - 42% increase in research interest 2. Semaglutide (GLP-1) - Steady baseline, most established 3. AOD-9604 - Growing interest for targeted fat loss **Average Research Protocols:** - Tirzepatide: 2.5-10mg weekly (titration approach most common) - Semaglutide: 0.5-2mg weekly - Combined protocols showing 15-25% better results in community reports **Interesting Observation:** Researchers who combine peptides with structured nutrition tracking report 2x better adherence and results compared to peptides alone. **Regional Variations:** - North America: Heavy focus on GLP-1 agonists - Europe: More balanced approach with growth peptides - Asia-Pacific: Increasing interest in combination protocols What trends are you seeing in your research? Let's discuss! *Data compiled from global research communities and published studies. For educational purposes only.*
1 Reply
Fascinating data! The regional variations are particularly interesting. I'm based in Europe and can confirm the balanced approach here - we see a lot more focus on growth peptides + healing peptides rather than just GLP-1s. The 15-25% better results with nutrition tracking makes total sense. Peptides are tools, not magic bullets. The lifestyle factors matter just as much. Would love to see more data on long-term outcomes (12+ months). Most studies are still relatively short-term.
Sign in to join the discussion
Sign InResearch Purposes Only: All discussions are for educational and research purposes. Not medical advice. Consult healthcare professionals before any protocol.